Nebenwirkungen · Bekemv
BEKEMV 300 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10
HOS-148440 · Präparat HOS-099910
MedDRA Very Common Uncommon Rare Not known system organ common (≥ 1/100 to (≥ 1/1 000 to (≥ 1/10 000 to (cannot be class (≥ 1/10) < 1/10) < 1/100) < 1/1 000) estimated from the available data) Infections and Pneumonia, Meningococcal Aspergillus infestations Upper infectionb, infectionc, respiratory tract Sepsis, Arthritis infection, Septic shock, bacterialc, Bronchitis, Peritonitis, Genitourinary Nasopharyngitis, Lower respiratory tract gonococcal Urinary tract tract infection, infection, infection, Fungal infection, Haemophilus Oral herpes Viral infection, infection, Abscessa, Impetigo Cellulitis, Influenza, Gastrointestinal infection, Cystitis, Infection, Sinusitis, Gingivitis Neoplasms Malignant benign, melanoma, malignant and Myelodysplastic unspecified syndrome (including cysts and polyps) Blood and Leucopenia, Thrombocytopenia, Haemolysis*, lymphatic Anaemia Lymphopenia Abnormal system clotting factor, disorders Red blood cell agglutination, Coagulopathy Immune system Anaphylactic disorders reaction, Hypersensitivity
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-15T13:22:00Z · SHA-256 d387d4b9d5a9018b26548a18de1ddda14618dff713302b935763ed70f39b9ee1 · Passage e094bc693e4b7fc8ce8974abf227c6740c69add73c23bacba605c5293db59dbd · Zeichen 1238–4098 im Abschnitt